Cingulate Inc. (CING:NASDAQ) closed at $4.57 on October 14, 2026, down 3.18% on the day. The stock trades 61.6% below its 52-week high of $11.89 and 44.6% above its 52-week low of $3.16. Over the past year, it gained 13.7%. Cingulate Inc. is part of the Health Care sector.
| 5D | 1M | 3M | 6M | 1Y |
|---|---|---|---|---|
| -3.48% | -8.70% | +6.55% | -13.39% | +13.73% |
In 252 trading sessions since October 14, 2025, CING closed higher on 130 days (52%). Its best day was March 16, 2026 (+23.36%) and its worst was March 18, 2026 (-31.05%). The stock moved 10% or more in a single session 13 times. It opened at least 5% above the previous day's high 1 time.
Cingulate Inc is a clinical stage biopharmaceutical company utilizing its proprietary precision timed release drug delivery platform to build and advance a pipeline of next-generation pharmaceutical products designed to improve the lives of patients suffering from frequently diagnosed conditions characterized by burdensome daily dosing regimens and suboptimal treatment outcomes.
Find more stocks like CING with the Spikes, Gaps, Breakouts and Performance Tracker scanners.
Based on end-of-day data. For information only, not investment advice.